GFA
PFE icon

Gallagher Fiduciary Advisors’s Pfizer PFE Stock Holding History

Gallagher Fiduciary Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-77,700
Closed -$3.11K – 218
2023
Q1 		$3.11K Buy
+77,700
New +$3.36M ﹤0.01% 200

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Gallagher Fiduciary Advisors's PFE Position: Q1 2026 in Review

Gallagher Fiduciary Advisors reduced its Pfizer (PFE) stake by 11% in Q1 2026, selling an estimated $98.4K and leaving 28,913 shares worth $812K. The position accounts for 0.03% of the portfolio, ranked #102.

Gallagher Fiduciary Advisors first reported a position in PFE in Q4 2014 and has held it in 15 quarters since. The position peaked at $102M in Q4 2014. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Gallagher Fiduciary Advisors held 28,913 shares of Pfizer worth $812K as of Q1 2026.
  • Gallagher Fiduciary Advisors sold 3,697 Pfizer shares in Q1 2026, an estimated $98.4K.
  • Pfizer made up 0.03% of Gallagher Fiduciary Advisors's portfolio in Q1 2026, its #102 holding.
  • Gallagher Fiduciary Advisors first reported a position in Pfizer in Q4 2014 and has held it in 15 quarters since.
  • Gallagher Fiduciary Advisors's Pfizer position peaked at $102M in Q4 2014.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Gallagher Fiduciary Advisors's 13F filing for Q1 2026, filed 15 May 2026.